Minimal-change renal disease and Graves’ disease: a case report and literature review

por Hasnain, Wirasat, Stillman, Isaac E., Bayliss, George P.
Publicado 2011

Kidney Transplant Outcomes in 2 Adults With Down Syndrome

por Henriksen, Kammi J., Chang, Anthony, Bayliss, George P.
Publicado 2018

The Diabetic Cardiorenal Nexus

por D’Elia, John A., Bayliss, George P., Weinrauch, Larry A.
Publicado 2022

Sodium–glucose cotransporter-2 inhibition and acidosis in patients with type 2 diabetes: a review of US FDA data and possible conclusions

por D’Elia, John A, Segal, Alissa R, Bayliss, George P, Weinrauch, Larry A
Publicado 2017

Do biologic markers predict cardiovascular end points in diabetic end-stage renal disease? A prospective longitudinal study

por Bayliss, George P., Weinrauch, Larry A., Gleason, Ray E., Lee, Annette T., D'Elia, John A.
Publicado 2013

Changes in treatment of hyperglycemia in a hypertensive type 2 diabetes population as renal function declines

por Weinrauch, Larry A., Segal, Alissa R., Bayliss, George P., Liu, Jiankang, Wisniewski, Eric, D’Elia, John A.
Publicado 2017

Kidney Mentoring and Assessment Program for Students: a guide for engaging medical students in nephrology

por Bayliss, George P, Cobb, Jason, Decker, Brian, Hellman, Richard, Vasavada, Nina, Mackelaite, Lina, Shadur, Craig, Ilori, Titilayo, Ibrahim, Tod, Leight, Katlyn, Hsiao, Li-Li, Molitoris, Bruce A, Okusa, Mark D, Parker, Mark G
Publicado 2019

Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan

por Chen, Dan-Qian, Cao, Gang, Chen, Hua, Argyopoulos, Christos P., Yu, Hui, Su, Wei, Chen, Lin, Samuels, David C., Zhuang, Shougang, Bayliss, George P., Zhao, Shilin, Yu, Xiao-Yong, Vaziri, Nosratola D., Wang, Ming, Liu, Dan, Mao, Jia-Rong, Ma, Shi-Xing, Zhao, Jin, Zhang, Yuan, Shang, You-Quan, Kang, Huining, Ye, Fei, Cheng, Xiao-Hong, Li, Xiang-Ri, Zhang, Li, Meng, Mei-Xia, Guo, Yan, Zhao, Ying-Yong
Publicado 2019